13F Holdings
中文EN

BYAH Park Ha Biological Technology Co., Ltd. Annual reports only

Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · Nasdaq · SEC CIK 1986247 · Fiscal year ends 10/31

Financial factors as of 2025-10-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY6.0%
TTM net income YoY-5,191.3%
TTM EPS YoY-4,410.4%
Revenue 3-yr CAGR9.6%
Net income 3-yr CAGR—

Margins

Gross margin94.4%
Operating margin-956.5%
Net margin-965.0%
FCF margin-0.1%
EBITDA margin-952.1%

Returns

ROE-885.8%
ROA-539.3%
ROIC (approx.)-3,273.0%
Asset turnover0.56x

Leverage & solvency

Liabilities / assets32.9%
Debt / equity0.00x
Current ratio2.92x
Interest coverage-588,997.59x

Cash quality & payout

Operating cash flow / net income-0.00x
Accruals ratio-541.2%
Payout ratio—
Capex / revenue3.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-10-31FY20242024-10-31FY20232023-10-31FY20222022-10-31
Income statement
Revenue$2.52M$2.38M$2.46M$1.92M
Cost of revenue$142,526$195,336$310,989$509,162
Gross profit$2.38M$2.19M$2.15M$1.41M
R&D expense$238,184$36,714$30,881$60,671
SG&A expense$25.48M$814,857$484,955$707,487
Operating income-$24.15M$793,714$1.18M$197,024
Interest expense$41——$194
Pretax income-$24.08M$793,421$1.18M$190,010
Income tax$280,646$314,860$329,527-$1,288
Net income-$24.36M$478,561$852,042$191,298
EBITDA-$24.04M$816,400$1.20M$227,515
EPS (basic)-41.380.961.700.01
EPS (diluted)-41.380.961.700.01
Weighted avg. shares (diluted)588,866500,000500,00025.00M
Balance sheet
Cash & equivalents$3.79M$547,498$1.03M$574,711
Receivables$255,844$330,892$361,735—
Inventory$75,214$71,486$95,870—
Current assets$5.50M$2.84M$2.18M—
PP&E, net$157,999$103,960$38,571—
Intangibles$6,639$7,621$8,404—
Total assets$5.95M$3.08M$2.26M—
Current liabilities$1.88M$1.52M$1.24M—
Total liabilities$1.96M$1.58M$1.25M—
Shareholders' equity$3.99M$1.51M$1.01M$150,277
Shares outstanding—25.00M25.00M—
Cash flow statement
Operating cash flow$85,852$960,470$126,537$1.44M
Capital expenditure$88,825$85,569$22,676$11,890
Free cash flow-$2,973$874,901$103,861$1.43M
Investing cash flow-$572,927-$508,143$1.02M-$1.55M
Financing cash flow$3.74M-$957,389-$676,925$669,652
Depreciation & amortization$109,369$22,686$20,063$30,491
Stock-based compensation$24.07M———

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.